[1]
Purmonen, T.T. et al. 2011. Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial. Acta Oncologica. 50, 3 (Apr. 2011), 344–352. DOI:https://doi.org/10.3109/0284186X.2011.553841.